Implantable system for treprostinil: a real‐world patient experience study-Reference-Cited by-同舟云学术

Implantable system for treprostinil: a real‐world patient experience study

Published:2020-04 Issue:2 Volume:10 Page:1-10
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Shapiro Shelley¹,Bourge Robert C.²,Pozella Patti³,Harris David F.⁴,Borg Erick H.³,Nelsen Andrew C.³

Affiliation:

1. VA Greater Los Angeles Healthcare SystemCardiology SectionDavid Geffen UCLA School of MedicineUCLA Medical Center Department of Pulmonary Critical CareLos AngelesCAUSA

2. Department of MedicineThe University of Alabama at BirminghamBirminghamALUSA

3. United Therapeutics CorporationResearch Triangle ParkNCUSA

4. Insight & MeasurementLLCDurhamNCUSA

Funder

United Therapeutics Corporation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894020907881

Reference34 articles.

1. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension;Galie N;Revista Espanola de Cardiologia (English ed),2016

2. Therapy for pulmonary arterial hypertension in adults 2018: update of the CHEST guideline and expert panel report;Klinger JR;Chest,2019

3. Subcutaneous treprostinil in congenital heart disease‐related pulmonary arterial hypertension;Skoro‐Sajer N;Heart (British Cardiac Society),2018

4. Safety, tolerability and clinical effects of a rapid dose titration of subcutaneous treprostinil therapy in pulmonary arterial hypertension: a prospective multi‐centre trial;Grunig E;Respiration,2016

5. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double‐blind, randomized, placebo‐controlled trial;Simonneau G;Am J Respir Crit Care Med,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges;APL Bioengineering;2023-09-01

2. Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension;Respiration;2023

3. Management of Idiopathic Pulmonary Arterial Hypertension in a Patient in Trinidad: A Case Report;Cureus;2022-09-28

4. Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension;Expert Review of Respiratory Medicine;2021-12-08

5. Pulmonary arterial hypertension: promising advances and remaining challenges;Journal of Investigative Medicine;2021-09-27